GR LIFE STYLE (00108) signs a strategic cooperation memorandum with Mingzhi Medical to jointly promote the in-depth integration and industrial upgrading of "medical + technology + scenarios".

GR LIFESTYLE (00108) announced on January 26, 2026, that the company has signed a strategic cooperation memorandum with Wise Medical Technology (Shanghai) Co., Ltd. According to the memorandum, the company and Wise Medical have preliminarily agreed to integrate their core resources, with artificial intelligence technology as the link, to deepen research in the real world of tumors and innovative research and development in traditional Chinese medicine, and to jointly promote the deep integration and industrial upgrading of "medical + technology + scenarios". The Group plans to leverage Wise Medical's technological and resource advantages to meet the current development needs of transitioning from traditional property and asset management to a DIGIHUMAN artificial intelligence technology medical service enterprise, thereby enhancing the diversity of the Group's business and creating future profit growth points. Specific cooperation directions include but are not limited to: building a digital marketing and health management system for pharmaceutical companies; and building a digital clinical trial collaboration platform. At the same time, the Group can also leverage its capital market advantages to deepen its cooperation with Wise Medical and promote the market expansion and further development of related cooperative businesses through the Company's brand effect. After signing the strategic cooperation memorandum, both parties will conduct market analysis and industry research on the DIGIHUMAN artificial intelligence technology medical service enterprise, and will soon begin personnel communication and on-site inspection work. The Group has two reportable operating segments, including the property management segment, which operates in China, and the property development and investment segment, which operates in China, the United States, and the United Kingdom. While continuing to expand the property management and property development and investment segments, the Group has also been exploring potential business opportunities, aiming to seek business diversification, broaden its sources of income, and ultimately improve shareholder returns. The directors believe that signing the strategic cooperation memorandum with Wise Medical will be beneficial for the Group's transition from traditional property and asset management to a DIGIHUMAN artificial intelligence technology medical service enterprise. This business activity can enhance the financial performance and profitability of the Group, aligning with the overall interests of the Company and its shareholders.